ArticleBMC medicine2021
Vaccination strategies for measles control and elimination: time to strengthen local initiatives.
Article in BMC medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 68 citations in OpenAlex.
- Measles Epidemiology, Transmission, and Surveillance Characteristics in Ethiopia, 2018-2024.Journal of epidemiology and global health · 2026Article
- An age-structured spatially varying coefficient model for high-resolution mapping of vaccination coverage.PLoS computational biology · 2026Article
- Formative qualitative assessment of caregiver barriers to childhood immunization in a Peri-urban District in Ghana.Discover public health · 2026Article
- Exploring supplemental immunization strategies to reach zero-dose children in low- and middle-income countries: a scoping review.Therapeutic advances in vaccines and immunotherapy · 2026Article
- Article
- Geospatial Mapping of Pediatric Febrile Illness in Uganda to Inform Precision Public Health Interventions.Open forum infectious diseases · 2026Article
- Recent Advances in Strategies Against Measles Spread: Clinical and Epidemiological Aspects, Impact, Vaccine Innovations, and Sustainable Recommendations.TheScientificWorldJournal · 2026Review
- Factors associated with laboratory-confirmed measles cases during the 2023 and 2024 outbreaks in Tanzania-a mixed-methods study.Frontiers in public health · 2026Article
- Article
- Health system and caregiver related factors influencing measles vaccination uptake: perspectives of Chadibe village, Botswana.BMC infectious diseases · 2025Article
- Spatio-Temporal Modelling and Forecasting of the Prolonged Measles Outbreak in Romania: Insights and Challenges.Healthcare (Basel, Switzerland) · 2025Article
- Modelling the relative contribution of infection, routine vaccination and supplementary immunisation activities to measles seroconversion in Kenyan Children.PLoS computational biology · 2025Article
- Investigating persistent measles dynamics associated with population immunity in Chad: a national secondary data model analysis from 2011 to 2025.IJID regions · 2025Article
- Article
- Vaccination Status and Incidences of Measles, Mumps, and Rubella - Worldwide, 2014-2023.China CDC weekly · 2025Article
- Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity.NPJ vaccines · 2025Article
- Inequalities in measles immunization coverage among two-year-olds in Sierra Leone, 2008-2019.BMC infectious diseases · 2024Article
- Article
- Wastewater Surveillance for Poliovirus in Selected Jurisdictions, United States, 2022-2023.Emerging infectious diseases · 2024Review
- Modelling the spatial variability and uncertainty for under-vaccination and zero-dose children in fragile settings.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThrough a combination of strong routine immunization (RI), strategic supplemental immunization activities (SIA) and robust surveillance, numerous countries have been able to approach or achieve measles elimination. The fragility of these achievements has been shown, however, by the resurgence of measles since 2016. We describe trends in routine measles vaccine coverage at national and district level, SIA performance and demographic changes in the three regions with the highest measles burden.
findingsWHO-UNICEF estimates of immunization coverage show that global coverage of the first dose of measles vaccine has stabilized at 85% from 2015 to 19. In 2000, 17 countries in the WHO African and Eastern Mediterranean regions had measles vaccine coverage below 50%, and although all increased coverage by 2019, at a median of 60%, it remained far below levels needed for elimination. Geospatial estimates show many low coverage districts across Africa and much of the Eastern Mediterranean and southeast Asian regions. A large proportion of children unvaccinated for MCV live in conflict-affected areas with remote rural areas and some urban areas also at risk. Countries with low RI coverage use SIAs frequently, yet the ideal timing and target age range for SIAs vary within countries, and the impact of SIAs has often been mitigated by delays or disruptions. SIAs have not been sufficient to achieve or sustain measles elimination in the countries with weakest routine systems. Demographic changes also affect measles transmission, and their variation between and within countries should be incorporated into strategic planning.
conclusionsRebuilding services after the COVID-19 pandemic provides a need and an opportunity to increase community engagement in planning and monitoring services. A broader suite of interventions is needed beyond SIAs. Improved methods for tracking coverage at the individual and community level are needed together with enhanced surveillance. Decision-making needs to be decentralized to develop locally-driven, sustainable strategies for measles control and elimination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.